ArticleFrontiers in pharmacology2022

Case Report: Severe thrombocytopenia induced by adalimumab in rheumatoid arthritis: A case report and literature review.

Tiantian Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.